ダウンロード数: 925

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
58_457.pdf902.31 kBAdobe PDF見る/開く
タイトル: 内分泌治療後, 腺癌から扁平上皮癌への分化が顕著となった前立腺癌の1例
その他のタイトル: Prostate Carcinoma with Squamous Differentiation after Combination Endocrine Therapy : A Case Report
著者: 長嶋, 隆夫  KAKEN_name
新納, 摩子  KAKEN_name
平山, きふ  KAKEN_name
伊達, 成基  KAKEN_name
沖原, 宏治  KAKEN_name
向所, 賢一  KAKEN_name
著者名の別形: Nagashima, Takao
Niiro, Mako
Hirayama, Kifu
Date, Seiki
Okihara, Koji
Mukaisho, Ken-ichi
キーワード: Prostate carcinoma
Squamous cell carcinoma
Endocrine therapy
発行日: Aug-2012
出版者: 泌尿器科紀要刊行会
誌名: 泌尿器科紀要
巻: 58
号: 8
開始ページ: 457
終了ページ: 460
抄録: We report a case of squamous differentiated prostate carcinoma that developed after combination endocrine therapy for adenocarcinoma of the prostate. The patient was a 68-year-old man who visited our hospital with microscopic hematuria. His serum prostate-specific antigen (PSA) level was 7. 06 ng/ml. Transperineal needle biopsy was performed and histological examinations indicated moderately differentiated adenocarcinoma with a Gleason score of 4+4=8. Computed tomography showed swelling of left external iliac lymph node. The clinical stage was T3aN1M0. Six weeks after combination endocrine therapy using goserelin acetate and bicalutamide, the patient underwent radical prostatectomy and bilateral pelvic lymphadenectomy. Histopathological examination of the surgical specimen demonstrated squamous cell carcinoma of the prostate with very small areas of adenocarcinoma. The treatment measure was changed from endocrine therapy to combination chemotherapy consisting of docetaxel, cisplatin, and 5- FU. Eighteen month has passed after the surgery without any evidence of distant metastasis.
著作権等: 許諾条件により本文は2013-09-01に公開
URI: http://hdl.handle.net/2433/159761
PubMed ID: 23052274
出現コレクション:Vol.58 No.8

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。